DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Social Networks
External Links
Hosting Providers

We began analyzing https://www.wjgnet.com/1007-9327/full/v22/i30/6876.htm, but it redirected us to https://www.wjgnet.com/1007-9327/full/v22/i30/6876.htm. The analysis below is for the second page.

Title[redir]:
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Description:
Mechanisms of drug resistance in colon cancer and its therapeutic strategies

Matching Content Categories {📚}

Science
Health & Fitness
Books & Literature

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌟 Strong Traffic: 100k - 200k visitors per month

Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, cited, rca, pubmed, resistance, cells, article, full, text, analysis, citation, doi, reference, drug, crossref, influence, colon, apoptosis, cell, transporters, pgp, abc, mrp, anticancer, multidrug, drugs, expression, inhibitors, death, autophagy, mechanisms, agents, human, protein, chemotherapy, bcrp, colorectal, res, pdf, proteins, patients, function, therapeutic, zhang, inhibition, efflux, treatment, induced, cancers, wang,

Topics {✒️}

epidermal-growth-factor-receptor mutation-positive article open-access policy retrovirus-mediated rna interference c-met/pi3k signaling[40] c-met/pi3k signaling hypoxia-inducible factor-1alpha hypoxia-inducible factor-1 alpha phosphatidylinositol 3-kinase/protein kinase anti-apoptotic signaling pathways cyclin-dependent kinase inhibitor glutathione s-transferase isoenzymes nitric oxide-related signalings authorship ethics committee hif-1α inhibition reversed atp-binding cassette transporters membrane-spanning alpha helices p-glycoprotein multidrug transporter anti-apoptotic protein bcl-2 multi-drug resistance protein-1 lrp/mvp occurs early open-label single-arm cancer-related deaths worldwide[1-3] steroidal anti-inflammatory drugs nonsteroidal anti-inflammatory drugs p53 wild-type cells[108] xeno-transplanted colorectal tumors[111] abc transporters mdr1/p-gp drug-resistant cancer cells fully peer-reviewed pseudomonas exotoxin-based proteins 2016 peer-review started publisher resources dihydrotanshinone induces p53-independent p53-dependent apoptosis modulates abcg2-mediated multidrug resistance p53-deficient cancer cells selective p-glycoprotein inhibitor concurrent noxa/bik induction dna-alkylating agent temozolomide reduce hif-1α level wild-type p53 function including pi3k/akt impairing dna-repair activity[117] sum=21464 publishing process article quality tracking bcl-2/bcl-xl antagonism pro-cell death function interest statement marine-derived triterpene sipholenol baishideng publishing group

Questions {❓}

Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
Generating inhibitors of P-glycoprotein: where to, now?

Social Networks {👍}(4)

External Links {🔗}(722)

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

5.5s.